Surgery for glaucoma ‐ 24 months · macular edema in diabetes
It is very uncertain whether intravitreal dexamethasone implant 0.7 mg changes surgery for glaucoma ‐ 24 months compared with intravitreal antiVEGF (very low certainty).
1 finding from 1 review
RR 3.02 [0.12, 73.56]
Studies not reported
Very low
Gain 3+ lines of visual acuity at 1 year · macular edema in diabetes
Intravitreal dexamethasone implant 0.7 mg showed no clear difference in gain of three or more lines visual acuity ‐ 12 months compared with sham (moderate certainty).
1 finding from 1 review
Change in retinal thickness (micron) (negative is better) · macular edema in diabetes
1 finding from 1 review
Cataract progression · macular edema in diabetes
Intravitreal dexamethasone implant 0.7 mg probably leads to higher cataract progression ‐ 36 months compared with sham (moderate certainty).
1 finding from 1 review
Use of IOP‐lowering medications · macular edema in diabetes
Intravitreal dexamethasone implant 0.7 mg probably leads to higher use of IOP‐lowering medications ‐ 36 months compared with sham (moderate certainty).
1 finding from 1 review
Surgery for glaucoma · macular edema in diabetes
Intravitreal dexamethasone implant 0.7 mg showed no clear difference in surgery for glaucoma ‐ 36 months compared with sham (low certainty).
1 finding from 1 review
Change in visual acuity (logMAR) ‐ 12 months (negative is better) · macular edema in diabetes
1 finding from 1 review
no estimate extracted
Studies not reported
Moderate
Gain 3+ lines of visual acuity at 1 year · macular edema in diabetes
Intravitreal dexamethasone implant 0.7 mg may leads to lower gain of three or more lines visual acuity ‐ 12 months compared with intravitreal antiVEGF (low certainty).
1 finding from 1 review
RR 0.99
Studies not reported
Low
Change in retinal thickness (micron) ‐ 12 months (negative is better) · macular edema in diabetes
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Health‐related quality of life · adults (>= 18 years) with an irreversible visual impairment
1 finding from 1 review
Vision‐related quality of life · adults (>= 18 years) with an irreversible visual impairment
1 finding from 1 review
Adverse events · adults (>= 18 years) with an irreversible visual impairment
1 finding from 1 review
Improved visual acuity (ETDRS chart at 4 metres) · participants with idiopathic macular hole
It is very uncertain whether face‐down positioning or posturing changes improved visual acuity (ETDRS chart at 4 metres) compared with no face‐down positioning or posturing after macular hole surgery (very low certainty).
1 finding from 1 review
Quality of life on a 0 to 100 scale. Various quality of life scales. (higher score is better) · participants with idiopathic macular hole
1 finding from 1 review
Mean IOP ( · Participants with acute primary angle closure after initial medical treatment to lower intraocular pressure
1 finding from 1 review
Mean change in angle findings, measured by any method · Participants with acute primary angle closure after initial medical treatment to lower intraocular pressure
1 finding from 1 review
Gonioscopic findings (Anterior segment optical coherence tomography parameters) (at 6 months) · participants with primary angle‐closure glaucoma
1 finding from 1 review
no estimate extracted
64 participants
GRADE not reported
Posterior capsule opacification score at one year As measured by AQUA score, Evaluation of PCO (EPCO) score and other methods of quantifying PCO · patients undergoing cataract surgery
1 finding from 1 review
Mean pupillary diameter—at the time the surgeon performs capsulorhexis (mm) · patients undergoing cataract surgery
1 finding from 1 review
Mean pupillary diameter—at the time the surgeon performs capsulorhexis (mm) · patients undergoing cataract surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found